Neoplasm by Histology clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Ph2 Study NKT2152 with Palbociclib & Sasanlimab in Subjects with Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
Sorry, in progress, not accepting new patients
The goal of the Lead-in phase of the study is to evaluate the safety, efficacy, pharmacokinetics (PK) and determine recommended dose for expansion (RDE) of NKT2152 in combination with palbociclib (Doublet) and with palbociclib and sasanlimab…
La Jolla, California and other locations
Last updated: